Alberto Fabbri
mc.manuscriptcentral.com
0000-0003-2603-9715
Azienda Ospedaliera Universitaria Senese
70 papers found
Refreshing results…
Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma
Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment
Treatment decisions and outcome in very elderly patients with diffuse large B‐Cell lymphoma
Primary Nasopharyngeal Hodgkin Lymphoma
Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma
Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: An Italian observational multicenter retrospective study in daily clinical practice
Low-dose chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab in follicular lymphoma
Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia
Atypical clinical presentation of visceral leishmaniasis in a patient with non-Hodgkin lymphoma
Hodgkin’s lymphoma as Richter’s transformation in chronic lymphocytic leukemia
Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas
Missing publications? Search for publications with a matching author name.